A proteomic clock of human pregnancy

[1]  I. Temel Yuksel,et al.  Evaluation of maternal serum hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  R. Tibshirani,et al.  An immune clock of human pregnancy , 2017, Science Immunology.

[3]  R. Romero,et al.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study , 2017, American journal of obstetrics and gynecology.

[4]  S. Cicero,et al.  Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[5]  A. Odibo.  Defining and diagnosing fetal growth restriction: the enigma continues , 2017, Acta Obstetricia et Gynecologica Scandinavica.

[6]  H. Alfthan,et al.  Low maternal pregnancy‐associated plasma protein A during the first trimester of pregnancy and pregnancy outcomes , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  Mark R Segal,et al.  Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease. , 2016, JAMA.

[8]  M. Tuuli,et al.  First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction. , 2016, Clinics in laboratory medicine.

[9]  T. Lo,et al.  Pregnancy-associated plasma protein A (PAPP-A) to predict adverse fetal outcomes in Chinese: What is the optimal cutoff value? , 2016, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[10]  A. Gupte,et al.  Correlation of first‐trimester serum levels of pregnancy‐associated plasma protein A with small‐for‐gestational‐age neonates and preterm births , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[11]  R. Anthony,et al.  Development of ovine chorionic somatomammotropin hormone-deficient pregnancies. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  D. Wright,et al.  Maternal serum alpha‐fetoprotein at 12, 22 and 32 weeks' gestation in screening for pre‐eclampsia , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  D. Wright,et al.  Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  D. Wright,et al.  Maternal serum soluble fms‐like tyrosine kinase‐1 at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  T. Morgan,et al.  Role of the Placenta in Preterm Birth: A Review , 2016, American Journal of Perinatology.

[16]  Christine L. Sun,et al.  Temporal and spatial variation of the human microbiota during pregnancy , 2015, Proceedings of the National Academy of Sciences.

[17]  C. Randazzo,et al.  Correlation of neonatal weight with maternal serum levels of pregnancy-associated plasma protein-A during the first trimester of pregnancy: a retrospective study , 2015, Journal of perinatal medicine.

[18]  R. Thadhani,et al.  Pathogenesis of preeclampsia , 2015, Current opinion in nephrology and hypertension.

[19]  S. Davidge,et al.  Molecular mechanisms of maternal vascular dysfunction in preeclampsia. , 2015, Trends in molecular medicine.

[20]  M. Kemp.  Preterm Birth, Intrauterine Infection, and Fetal Inflammation , 2014, Front. Immunol..

[21]  Larry Gold,et al.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.

[22]  S. Illanes,et al.  Innate Immune System and Preeclampsia , 2014, Front. Immunol..

[23]  M. Torloni,et al.  Proteomic Biomarkers for Spontaneous Preterm Birth , 2014, Reproductive Sciences.

[24]  M. Turner,et al.  A review of contemporary modalities for identifying abnormal fetal growth , 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[25]  G. Shaw,et al.  Transdisciplinary translational science and the case of preterm birth , 2012, Journal of Perinatology.

[26]  A. Dessì,et al.  Physiopathology of intrauterine growth retardation: from classic data to metabolomics , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  F. Schattenberg,et al.  Trophoblastic progranulin expression is upregulated in cases of fetal growth restriction and preeclampsia , 2012, Journal of perinatal medicine.

[28]  C. Sephton,et al.  Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration* , 2012, The Journal of Biological Chemistry.

[29]  M. Tuuli,et al.  Efficiency of first‐trimester growth restriction and low pregnancy‐associated plasma protein‐A in predicting small for gestational age at delivery , 2012, Prenatal diagnosis.

[30]  J. Shioi,et al.  Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling , 2011, Neurobiology of Aging.

[31]  M. Cynader,et al.  Progranulin Deficiency Decreases Gross Neural Connectivity But Enhances Transmission at Individual Synapses , 2011, The Journal of Neuroscience.

[32]  K. Pulkki,et al.  Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[33]  Zhinan Yin,et al.  The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice , 2011, Science.

[34]  B. Gerber,et al.  Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo. , 2011, The Journal of reproduction and development.

[35]  Jason Gardosi,et al.  Clinical strategies for improving the detection of fetal growth restriction. , 2011, Clinics in perinatology.

[36]  A. Goate,et al.  Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β , 2010, Protein & Cell.

[37]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[38]  Jian Q. Feng,et al.  Granulin epithelin precursor: a bone morphogenic protein 2‐inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  D Timmerman,et al.  New crown–rump length curve based on over 3500 pregnancies , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[40]  M. Laan,et al.  Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. , 2010, The Journal of clinical endocrinology and metabolism.

[41]  C. Iadecola,et al.  Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice , 2010, The Journal of experimental medicine.

[42]  B. Beutler.  TLRs and innate immunity. , 2009, Blood.

[43]  M. Peters,et al.  Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. , 2008, Histology and histopathology.

[44]  J. Ring,et al.  Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. , 2008, The Journal of clinical investigation.

[45]  Y. Taketani,et al.  Prolactin can modulate CD4+ T‐cell response through receptor‐mediated alterations in the expression of T‐bet , 2008, Immunology and cell biology.

[46]  J. Filmus,et al.  Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. , 2008, The Biochemical journal.

[47]  Larry Gold,et al.  Proteomics and diagnostics: Let's Get Specific, again. , 2008, Current opinion in chemical biology.

[48]  D. Hume,et al.  The transcriptional regulation of the Colony-Stimulating Factor 1 Receptor (csf1r) gene during hematopoiesis. , 2008, Frontiers in bioscience : a journal and virtual library.

[49]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[50]  L. Mulligan,et al.  RET Signaling in Endocrine Tumors: Delving Deeper into Molecular Mechanisms , 2007, Endocrine pathology.

[51]  Y. Miyagi,et al.  Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. , 2007, Placenta.

[52]  Anthony A Kossiakoff,et al.  Crystal structure and site 1 binding energetics of human placental lactogen. , 2006, Journal of molecular biology.

[53]  H Almström,et al.  Ultrasound dating at 12–14 weeks of gestation. A prospective cross‐validation of established dating formulae in in‐vitro fertilized pregnancies , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[54]  C. Kaetzel.  The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces , 2005, Immunological reviews.

[55]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[56]  P G Lindqvist,et al.  Does antenatal identification of small‐for‐gestational age fetuses significantly improve their outcome? , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[57]  J. Filmus,et al.  The Loss of Glypican-3 Induces Alterations in Wnt Signaling* , 2005, Journal of Biological Chemistry.

[58]  F. Malone,et al.  First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). , 2004, American journal of obstetrics and gynecology.

[59]  N. Skakkebaek,et al.  A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. , 2004, The Journal of clinical endocrinology and metabolism.

[60]  Tianhua Huang,et al.  Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. , 2003, American journal of obstetrics and gynecology.

[61]  H. Erdjument-Bromage,et al.  Conversion of Proepithelin to Epithelins Roles of SLPI and Elastase in Host Defense and Wound Repair , 2002, Cell.

[62]  M. Buemi,et al.  Is mid‐trimester maternal serum inhibin‐A a marker of preeclampsia or intrauterine growth restriction? , 2002, Acta obstetricia et gynecologica Scandinavica.

[63]  Gordon C. S. Smith,et al.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. , 2002, The Journal of clinical endocrinology and metabolism.

[64]  D. Schlessinger,et al.  Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. , 2001, Histology and Histopathology.

[65]  G. Greisen,et al.  Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth. , 2000, Early human development.

[66]  S. Handwerger,et al.  The Roles of Placental Growth Hormone and Placental Lactogen in the Regulation of Human Fetal Growth and Development , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[67]  P. Grøttum,et al.  Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown‐rump length and biparietal diameter , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[68]  H. Jabbour,et al.  Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. , 1998, The Journal of clinical endocrinology and metabolism.

[69]  P. Kelly,et al.  Prolactin: A Hormone at the Crossroads of Neuroimmunoendocrinology , 1998, Annals of the New York Academy of Sciences.

[70]  高畑 淳子,et al.  Pregnancy-associated plasma protein A (PAPP-A)を用いた妊娠初期における染色体異常スクリーニングの検討 , 1997 .

[71]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[72]  P. Kelly,et al.  Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. , 1994, Endocrinology.

[73]  J. MacLeod,et al.  Developmental control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster. , 1992, The Journal of biological chemistry.

[74]  L. Cole,et al.  Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. , 1988, Endocrinology.

[75]  J. Grudzinskas,et al.  Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation , 1984, British journal of obstetrics and gynaecology.

[76]  T. Chard,et al.  Maternal blood levels of human placental lactogen in the prediction of fetal growth retardation: choosing a cut‐off point between normal and abnormal , 1983, British journal of obstetrics and gynaecology.

[77]  Birk Sa,et al.  Human placental lactogen and intrauterine growth retardation. , 1976 .

[78]  B. Saxena,et al.  Results of the First 1000 Radioreceptorassays for the Determination of Human Chorionic Gonadotropin: A New, Rapid, Reliable, and Sensitive Pregnancy Test *† , 1976 .

[79]  W. Spellacy,et al.  Human Placental Lactogen and Intrauterine Growth Retardation , 1976, Obstetrics and gynecology.